S&P 500 Consumer Staples Sector SEC Filings — February 02, 2026

03-02-2026

Steele Bancorp Inc filed an 8-K on 2026-02-03 disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific financial metrics, revenue, earnings, or period-over-period comparisons were detailed in the provided filing information. This appears to be a standard voluntary earnings-related disclosure.

03-02-2026

ClearOne Inc filed a Form 8-K on 2026-02-03 reporting under Item 1.01 entry into a Material Definitive Agreement. Item 9.01 discloses Financial Statements and Exhibits in support. No details on the agreement terms, parties, financial impacts, or quantitative metrics are provided.

• ·AccNo: 0001753926-26-000244
• ·File Size: 250 KB
• ·Sector: NOT_DISCLOSED

03-02-2026

Emerson Electric Co filed a Form 8-K on February 3, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This discloses financial results but no specific revenue, earnings, margins, guidance, or period-over-period comparisons are mentioned in the provided filing details. No positive, negative, or flat metrics are available.

03-02-2026

Powell Industries Inc filed a Form 8-K on February 3, 2026 (AccNo: 0000080420-26-000013), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing announcing financial results, but specific revenue, earnings, or other quantitative metrics are NOT_DISCLOSED. No positive or negative performance details, guidance, or comparisons are provided in the available information.

03-02-2026

Electronic Arts Inc. filed an 8-K on February 3, 2026 (AccNo: 0000712515-26-000012), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing announcing financial results, but no specific revenue, earnings, guidance, or other quantitative metrics are disclosed in the provided information. No positive or negative performance indicators, period-over-period changes, or transaction details are mentioned.

03-02-2026

Archer-Daniels-Midland Co filed an 8-K on February 3, 2026, reporting Results of Operations and Financial Condition under Item 2.02, accompanied by Financial Statements and Exhibits under Item 9.01. This is a standard earnings-related disclosure, but no specific revenue, earnings, margins, period-over-period changes, or other quantitative financial metrics were detailed in the provided filing information. No positive or negative performance indicators, guidance, or operational details were disclosed.

03-02-2026

Artificial Intelligence Technology Solutions Inc. filed an 8-K on February 3, 2026, disclosing under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events, financial statements, exhibits, transaction values, metrics, or impacts are provided in the filing summary. Critical information such as dollar values, percentages, or strategic context is NOT_DISCLOSED.

03-02-2026

THUNDER MOUNTAIN GOLD INC filed an 8-K on 2026-02-03 reporting Item 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), Item 5.07 (Submission of Matters to a Vote of Security Holders), and Item 9.01 (Financial Statements and Exhibits). No specific details on the amendments, shareholder vote matters or outcomes, fiscal year changes, or contents of exhibits are disclosed. This is a multi-item informational filing with no quantified financial or operational metrics provided.

03-02-2026

CorVel Corp filed an 8-K on February 3, 2026, reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits under Item 9.01. No specific revenue, earnings, guidance, or other financial metrics are disclosed in the provided filing information. No positive or negative performance indicators, period-over-period comparisons, or strategic details are mentioned.

03-02-2026

Atkore Inc. filed a Form 8-K on February 3, 2026 (AccNo: 0001628280-26-004737), disclosing under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits), indicating a financial results announcement. This is a multi-item filing typical for earnings releases, but no specific revenue, earnings, guidance, or other quantitative metrics are explicitly stated in the provided information. No positive or negative performance indicators, period-over-period changes, or balance sheet effects are disclosed.

03-02-2026

Ellington Financial Inc. filed an 8-K on February 3, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. No specific details, financial metrics, transactions, or events are disclosed in the provided filing information. This is a multi-item voluntary filing with no quantitative data available.

03-02-2026

Massimo Group filed an 8-K on February 3, 2026, disclosing under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other event, financial statements, exhibits, transaction values, or performance metrics are provided in the filing summary. This appears to be a multi-item informational filing with no disclosed quantitative impacts.

03-02-2026

PepsiCo Inc filed an 8-K on February 3, 2026 (AccNo: 0000077476-26-000009), reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, margins, guidance, or period-over-period comparisons are disclosed in the provided filing details. This is a standard earnings-related disclosure without quantified metrics.

03-02-2026

ARKO Corp. filed an 8-K on 2026-02-03 disclosing results of operations and financial condition under Item 2.02, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. No specific revenue, earnings, balance sheet effects, guidance, or period-over-period comparisons were mentioned. No positive, negative, or flat performance metrics were detailed in the provided filing information.

03-02-2026

BICYCLE THERAPEUTICS PLC filed an 8-K on 2026-02-03 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals, reasons for change, timing, or financial impacts are provided. No quantitative metrics, performance data, or scheduled events are mentioned.

• ·AccNo: 0001104659-26-009501
• ·File size: 256 KB
• ·Sector: not specified

03-02-2026

BellRing Brands, Inc. filed an 8-K on February 3, 2026 (AccNo: 0001628280-26-004789), disclosing results of operations and financial condition under Item 2.02 and an officer change or related event under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements). Item 9.01 references financial statements and exhibits. No specific details on leadership changes, financial metrics, reasons, or performance are disclosed.

03-02-2026

Relay Therapeutics, Inc. filed a Form 8-K on February 3, 2026, under Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the core events, transactions, financial metrics, or impacts provided in the filing summary. No quantitative data, guidance changes, or scheduled events are disclosed.

03-02-2026

Hubbell Inc filed an 8-K on 2026-02-03 under Item 2.02 for Results of Operations and Financial Condition and Item 9.01 for Financial Statements and Exhibits. This is a standard disclosure for financial results with attached exhibits, likely including an earnings press release. No specific revenue, earnings, guidance, period-over-period changes, or other quantitative metrics are disclosed in the provided filing information.

03-02-2026

CLARIVATE PLC filed an 8-K on February 3, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. No specific details, financial metrics, transactions, or performance data are disclosed in the filing summary. No positive, negative, or flat metrics are mentioned.

03-02-2026

Beeline Holdings, Inc. filed an 8-K on February 3, 2026 (AccNo: 0001493152-26-004838, Size: 233 KB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific core event, financial metrics, transactions, or performance details (positive, negative, or flat) are disclosed in the filing summary. This appears to be a voluntary informational disclosure with attached exhibits.

03-02-2026

Sangamo Therapeutics, Inc. filed a Form 8-K on 2026-02-03 disclosing results of operations and financial condition under Item 2.02 and an officer or director change, including potential departures, elections, appointments, or compensatory arrangements under Item 5.02. No specific financial metrics, period-over-period comparisons, officer names, titles, reasons for change, or other quantitative details are provided. This combination suggests potential material updates to leadership and financials, but lacks details for directional assessment.

03-02-2026

Prelude Therapeutics Inc filed a Form 8-K on February 3, 2026, under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing involving a voluntary disclosure of potentially material information via Regulation FD, with exhibits attached. No specific details, financial metrics, transactions, or quantitative data are disclosed in the provided filing summary.

03-02-2026

Mueller Industries Inc filed an 8-K on February 3, 2026, reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, margins, guidance, or period-over-period comparisons are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure without detailed metrics available.

03-02-2026

Northfield Bancorp, Inc. filed an 8-K on February 3, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, period-over-period comparisons, or quantitative data are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure without detailed performance indicators.

03-02-2026

iQSTEL Inc filed an 8-K on February 3, 2026, reporting under Item 3.03 material modifications to rights of security holders and under Item 5.03 amendments to articles of incorporation or bylaws or change in fiscal year, with Item 9.01 listing financial statements and exhibits. No quantitative financial metrics, transaction values, or specific details on the modifications or amendments are disclosed in the provided filing summary. No positive or negative performance metrics are mentioned.

03-02-2026

DIAMOND HILL INVESTMENT GROUP INC filed a Form 8-K on February 3, 2026, under Item 8.01 Other Events. No specific details regarding the event, financial metrics, transactions, or impacts are disclosed in the provided filing information. No quantitative data, period-over-period comparisons, or scheduled events are mentioned.

03-02-2026

Bridgeline Digital, Inc. filed a Form 8-K on 2026-02-03 under Item 3.01 announcing a notice of delisting or failure to satisfy a continued listing rule or standard, or transfer of listing. No financial metrics, quantitative impacts, positive developments, or other details were disclosed in the filing summary. This event signals potential removal from a major US exchange.

03-02-2026

Mountain Lake Acquisition Corp. II filed an 8-K on 2026-02-03 under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits) related to a merger/acquisition event. No specific deal structure, parties, valuation, financial terms, synergies, regulatory details, or quantitative metrics are disclosed in the provided filing summary. No positive or negative performance metrics, scheduled events, or forward-looking statements are mentioned.

03-02-2026

Rigel Pharmaceuticals Inc filed an 8-K on 2026-02-03 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals, reasons for change, timing, or terms were provided. No quantitative financial metrics, performance comparisons, or other numerical data were mentioned.

03-02-2026

Piedmont Realty Trust, Inc. filed an 8-K on 2026-02-03 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 indicates financial statements and exhibits were included. Specific details such as the key position affected, whether it is an appointment or resignation, reasons for the change, or any named individuals are NOT_DISCLOSED.

03-02-2026

Ridgefield Acquisition Corp filed an 8-K on 2026-02-03 disclosing Item 3.03 Material Modifications to Rights of Security Holders, likely related to a merger/acquisition event. Item 9.01 includes Financial Statements and Exhibits. No quantitative details, parties, deal terms, or performance metrics are explicitly stated.

03-02-2026

Mondelez International, Inc. filed an 8-K on February 03, 2026, under Item 2.02 disclosing results of operations and financial condition, accompanied by Item 9.01 for financial statements and exhibits. No specific revenue, earnings, margins, guidance, or period-over-period comparisons are disclosed in the provided filing information. This is a standard earnings-related disclosure with no quantified metrics available.

03-02-2026

Zurn Elkay Water Solutions Corp filed an 8-K on February 3, 2026, reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, margins, guidance, or period-over-period comparisons are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure with no quantified positive or negative metrics available.

03-02-2026

Exelon Corp filed an 8-K on 2026-02-03 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for change, timing, or any quantitative impacts are disclosed. This represents a standard governance event with no additional metrics provided.

03-02-2026

Intapp, Inc. filed an 8-K on 2026-02-03 disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01 (file size 503 KB). No specific revenue, earnings, margins, or other financial metrics are explicitly stated in the provided filing details. No positive or negative performance indicators, comparisons, or guidance are mentioned.

03-02-2026

Clorox Co /DE/ filed an 8-K on February 3, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results but provides no specific revenue, earnings, or other quantitative metrics in the available filing summary. No positive, negative, or flat performance indicators are detailed.

03-02-2026

Benchmark Electronics Inc filed an 8-K on February 3, 2026 (AccNo: 0001193125-26-035656), disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, margins, guidance, or other quantitative financial metrics are explicitly stated in the provided filing information. This is a standard earnings-related disclosure with no period-over-period comparisons or directional performance data available.

03-02-2026

Atmos Energy Corp filed an 8-K on February 3, 2026, reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, margins, or period-over-period comparisons were disclosed in the filing metadata. This represents a standard voluntary disclosure of quarterly or periodic financial results.

03-02-2026

Accel Entertainment, Inc. filed an 8-K on 2026-02-03 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on positions affected, individuals involved, reasons for change, or quantitative impacts are disclosed.

03-02-2026

KKR Real Estate Finance Trust Inc. filed an 8-K on February 3, 2026 (AccNo: 0001628280-26-005088, Size: 6 MB), reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, balance sheet changes, period-over-period comparisons, or other quantitative financial metrics were disclosed in the provided filing summary. No positive, negative, or flat performance indicators were detailed.

03-02-2026

Reliance Global Group, Inc. filed a Form 8-K on February 3, 2026, disclosing entry into a material definitive agreement under Item 1.01, other events under Item 8.01, and financial statements and exhibits under Item 9.01. No specific details on the agreement, events, transaction values, financial impacts, or other metrics are disclosed in the provided filing summary. This is a multi-item filing with no quantitative data or period-over-period comparisons available.